(Date:5/20/2008)...rs Facing Combat-Related Eye Trauma and Vision ...SHINGTON, May 20 /PRNewswire-USNewswire/ -- Eye wo...g the most common types of injury,for America,s so...q and,Afghanistan. On May 19, 2008 at Walter Reed ... John Boozman, O.D. (R-AR), incoming American,Opto...
(Date:5/20/2008)...ire/ -- On May 25, one bright,yellow IndyCar, the ...o win,the Indianapolis 500 bearing the symbol of a...By emblazoning their car on both sides with the lo...org, IndyCar owners Jay Penske,and Steve Luczo of...s,veteran Tomas Scheckter of South Africa, add the...
(Date:5/20/2008)...0,000 uninsured residents, DETROIT, May 20 /PRNew...provide low- or no-cost health care to 90,000 unin...Blue Cross Blue Shield of Michigan. The grants,bri...million since 2005., Supporting free clinics is p... affordable health care and improve access to heal...
(Date:5/20/2008)...l CT scans of low-risk patients are almost always ...rding to a large study of patients. This finding ...are seen in about 5% of CT examinations, study aut... 1,049 adrenal masses, who had no history of malig... adrenal mass, said Julie H. Song, MD, lead author...
Breaking Medicine News(10 mins):Health News:Rep. Boozman, AOA Officials Tour Military Eye Care Facilities at Walter Reed Army Medical Center 2Health News:Rep. Boozman, AOA Officials Tour Military Eye Care Facilities at Walter Reed Army Medical Center 3Health News:Rep. Boozman, AOA Officials Tour Military Eye Care Facilities at Walter Reed Army Medical Center 4Health News:Luczo Dragon IndyCar Carries 'Eyes on the Road' Logo to Prevent Blindness to Indy 500 2Health News:Forty-Two Free Clinics Across State Share $1 Million in Grants From Blue Cross Blue Shield of Michigan 2Health News:Forty-Two Free Clinics Across State Share $1 Million in Grants From Blue Cross Blue Shield of Michigan 3Health News:Forty-Two Free Clinics Across State Share $1 Million in Grants From Blue Cross Blue Shield of Michigan 4...ly of enzymes called sirtuins, which can dramatica..., worms, and flies. Now, a new study from scienti...tegy for activating sirtuins to unleash their anti...o control age-associated metabolic disorders, incl...
... professor in Indiana University Bloomington's Dep...ome tips to help parents of teenagers have a conve...ge is the most difficult phase in the process of g...tegral part of this mind-boggling time. The resear...
... Biotech have been developing a harmless virus as ...accumulating data that suggests in addition to dir...the immune system to mount a separate, powerful an... Evidence for this theory has been mounting for ...
...cal journal The Lancet claims that a newer class o...his research carried out by Merck employees was co...dently. Patients suffering from arthritis general...s (NSAIDS) like Aspirin and ibuprofen. Ulcers and ...
Other Medicine News:Health News:Anti-Aging Powers of Enzyme Sirtuins 2Health News:Scientists Develop a Harmless Multi-Tasking Reovirus 2(Date:5/19/2008)... Nektar Therapeutics present preliminary Phase II ...ia in intubated and mechanicall... /- Bayer HealthCare,togeth...y presented positive,preliminary Phase II data on ...le at the American Thoracic Society (ATS) annual m...
(Date:5/19/2008)...Be Presented at the 2008 Annual European Congress ...Against Rheumatism (EULAR) -, - Initiation of Pha... of 2008 -, SAN D...iences, Inc.,(Nasdaq: RDEA ) today announced the ...or the treatment of patients with gout, RDEA594. G...
(Date:5/19/2008)..., May 19 /- IPSOGEN SA (Marseille and...arkets molecular diagnostic,assays for blood & bre...,the University of Texas MD Anderson Cancer Center...two studies on the Genomic Grade index (GGi) at th... to June 3, 2008. The data,indicate that the Genom...
(Date:5/18/2008)...a Demonstrated Higher Overall Maintenance of Heale...rsus Placebo --, SAN DIEGO, May 18 /...results from three pivotal Phase 3 studies evaluat...proton pump inhibitor (PPI),with an innovative dua...with erosive esophagitis (EE) and in maintenance o...
Breaking Medicine Technology:Amikacin Inhale Shows Promising Results in Phase II Study 2Amikacin Inhale Shows Promising Results in Phase II Study 3Amikacin Inhale Shows Promising Results in Phase II Study 4Amikacin Inhale Shows Promising Results in Phase II Study 5Amikacin Inhale Shows Promising Results in Phase II Study 6Amikacin Inhale Shows Promising Results in Phase II Study 7Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 2Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 3Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 4Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 5Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer 2Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer 3Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer 4TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis 2TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis 3TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis 4Breakthrough in Pulmonary Drug Delivery will Bring Numerous In Hospital Treatments to the Home 8547 1Breakthrough in Pulmonary Drug Delivery will Bring Numerous In Hospital Treatments to the Home 8547 2LineaGen Inc Launches With Close of 245 8 Million Series A Funding Round 2302 1LineaGen Inc Launches With Close of 245 8 Million Series A Funding Round 2302 2LineaGen Inc Launches With Close of 245 8 Million Series A Funding Round 2302 3LineaGen Inc Launches With Close of 245 8 Million Series A Funding Round 2302 4Possible New Way to Detect Monitor Liver Disease Without Painful Liver Biopsy 2297 1Possible New Way to Detect Monitor Liver Disease Without Painful Liver Biopsy 2297 2Skatepark injuries can incur economic pain 8540 1Skatepark injuries can incur economic pain 8540 2...-(BUSINESS WIRE)--Apr 13, 2007 - Point Therapeutic... presentation of,preclinical data at the 2007 Annu...Research (AACR) taking place in Los Angeles,Calif...tions report,on preclinical studies on talabostat,...or the AACR presentations are as,follows: , Presen...
...GO--(BUSINESS WIRE)--Apr 13, 2007 - Ascenta Therap...le portfolio of,apoptosis-triggering compounds wil...ral poster presentations at next week,s 2007,Annua...esearch,(AACR), to be held in Los Angeles, Califor... been selected for presentation at the,"High Impac...
Other Medicine Technology:Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 2Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 3Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 4Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 5Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 6Siemens Webcast: Expert Insight - Key Elements for a Successful Electrophysiology Program
...LEXILOG antimony pH catheters are designed for pat...ll catheters are number marked at 5cm intervals an...en individual models are available spanning most c...se or multi-use models with one or two sensors., ...
...limline multi-use catheters are designed using est...ution with the following benefits:, ,Working with...res where the multi-use catheter is used the Helli...n.,NOTE: ,Medtronic pH measurement systems have be...
FLEXILOG spare part.
Medicine Products: